Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Deaf mice cured with gene therapy

Published 09/01/2015, 03:03 PM
Updated 09/01/2015, 03:07 PM
© Reuters. An artist's impression of a large, active predator called Pentecopterus decorahensis that lived 467 million years ago during the Ordovician Period

Boston, Massachusetts - In a laboratory at Boston Children's Hospital a cure for genetic deafness is taking shape. Lead researcher Jeff Holt says that if all goes as planned, children of the future who lose their ability to hear due to genetic mutation will never go deaf.

Holt and his fellow researchers are attacking the problem at its source. They are using engineered viruses to repair damaged genes that make up parts of the inner ear.

"Our strategy was to take a viral vector, remove the viral genes so that it doesn't make anyone sick and to replace those with the correct DNA sequence for TMC1," said Holt, an associate professor of Otolaryngology. 

TMC1 is a gene critical to hearing. It is responsible for encoding proteins that convert sound into electrical signals the brain can process.

To test their treatment protocol, Holt and his team used two types of deaf mice that model the dominant and recessive genetic mutations of TMC1 in humans. The team used an engineered virus called adeno-associated virus, or AAV1, to deliver the functioning TMC1 gene to the inner ears of the deaf mice models. 

"We found that we can restore function in both cases for recessive and dominant forms of TMC1 mutations," he said. 

While genetic testing and brain activity showed the treatment worked, the researchers still needed to find out if the deaf mice could actually hear. For that they placed the treated mice in a chamber with sensors and speakers that produced loud, abrupt, sounds. 

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We can't really ask a mouse if they are able to hear but we can play a loud sudden sound and a normal mouse will jump in response to that, a deaf mouse does not move at all but after our gene therapy treatment the deaf mice began to jump," Holt said. 

Holt says there at least 70 different mutations that cause one in one thousand people too go deaf in adolescence. He says this gene therapy platform could potentially lead to treatment for all of them, ensuring that in the future, no child ever loses their ability to hear due to genetic mutation.    OLUSSCIENCE Reuters US Online Report Science News 20150901T170707+0000

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.